Do women have worse outcome after stroke caused by intracranial arterial stenosis?

Stroke

Volumn 38, Issue 7, 2007, Pages 2025-2027

  Rundek, Tatjana ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Minorities; Outcome; Women

Indexed keywords

ARTERY OCCLUSION; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CULTURAL FACTOR; EDITORIAL; EDUCATION; EVIDENCE BASED MEDICINE; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SOCIAL ASPECT; STROKE; TRANSCRIPTION REGULATION;

CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; MALE; PROGNOSIS; RISK FACTORS; SEX FACTORS;

EID: 34347325186     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.487397     Document Type: Editorial

References (20)

1. American Heart Asociation. American Stroke Association. Heart disease and stroke statistics 2005 Update. Available at http://americanheart.org/download/ heart.
2. Ayala C, Croft JB, Greenlund KJ, Keenan NL, Donehoo RS, Malarcher AM, Mensah GA. Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998. Stroke. 2002;33:1197-1201.
3. Sheikh K, Bullock CM. Effect of measurement on sex difference in stroke mortality. Stroke. 2007;38:1085-1087.
4. Arnold M, Kappeler L, Nedeltchev K, Brekenfeld C, Fischer U, Keserue B, Remonda L, Schroth G, Mattle HP. Recanalization and outcome after intra-arterial thrombolysis in middle cerebral artery and internal carotid artery occlusion: does sex matter? Stroke. 2007;38(4):1281-1285.
5. Kent DM, Price LL, Ringleb P, Hill MD, Selker HP. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke. 2005;36:62-65.
6. Savitz SI, Schlaug G, Caplan L, Selim M. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke. 2005;36:1447-1451.
7. Williams JE, Chimowitz MI, Cotsonis GA, Lynn MJ, Waddy SP; for the WASID Study Group. Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke. 2007;38:2055-2062.
8. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1588.
9. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-559.
10. Grundy S, Pasternak R, Greenland P, Smith S Jr, Fuster V. AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 1999;34:1348-1359.
11. Genest J, Frohlich J, Fodor G, McPherson R. Working Group on Hypercholesterolemia and Other Dyslipidemias. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ. 2003;169:921-924.
12. National Cholesterol Education Program (NCEP) Expert Panel on Detection; Evaluation and Treatment of High Blood Cholesterol in Adults. (Adult Treatment Panel III). Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
13. Heisler M, Langa KM, Eby EL, Fredrick AM, Kabeto MU, Piette JD. The health effects of restricting prescription medication use because of cost. Med Care. 2004;42:626-634.
14. Boden-Albala B, Litwak E, Elkind MS, Rundek T, Sacco RL. Social isolation and outcomes post stroke. Neurology. 2005;64:1888-1892.
15. Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D'Agostino RB, Detrano RC, Herrington DM. Gender and hs-C-Reactive Protein: Data from the Multi-Ethnic Study of Atherosclerosis (MESA) Cohort. AHJ. 2006;152:593-598.
16. Khor LL, Muhlestein JB, Carlquist JF, Horne BD, Bair TL, Maycock CA, Anderson JL; Intermountain Heart Collaborative Study Group. Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery disease. Am J Med. 2004;117:657-664.
17. Bertran N, Camps J, Fernandez-Ballart J, Arija V, Ferre N, Tous M, Simo D, Murphy MM, Vilella E, Joven J. Diet and lifestyle are associated with serum C-reactive protein concentrations in a population-based study. J Lab Clin Med. 2005;145:41-46.
18. Hellings WE, Pasterkamp G, Verhoeven BA, De Kleijn DP, De Vries JP, Seldenrijk KA, van den Broek T, Moll FL. Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy. J Vasc Surg. 2007;45:289-296.
19. Rothwell M, ACST: which subgroups will benefit most from carotid endarterectomy? Lancet. 2004;364:1122-1123.
20. Pilote L, Dasgupta K, Guru V, Humphries KH, McGrath J, Norris C, Rabi D, Tremblay J, Alamian A, Barnett T, Cox J, Ghali WA, Grace S, Hamet P, Ho T, Kirkland S, Lambert M, Libersan D, O'Loughlin J, Paradis G, Petrovich M, Tagalakis V. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ. 2007;176:S1-S43.